Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropeniaCurtis L Cooper, Saif Al-Bedwawi, Craig Lee, et al.
Immunology|December 22, 2017
Hepatitis C virus core protein reduces CD8+ T-cell proliferation, perforin production and degranulation but increases STAT5 activationSarwat Tahsin Khan, Winston Karges, Curtis L Cooper, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 2, 2013
Parasitic disease screening among HIV patients from endemic countries in a Toronto clinicCecilia T Costiniuk, Curtis L Cooper, Steve Doucette, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 28, 2017
Liver enzyme normalization predicts success of Hepatitis C oral direct-acting antiviral treatmentSarwat T Khan, Michaeline McGuinty, Daniel J Corsi, et al.
Cells|March 20, 2019
Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose ParametersMary-Anne Doyle, Chrissi Galanakis, Erin Mulvihill, et al.
Cells|April 28, 2019
Chronic Hepatitis C Virus Infection Impairs M1 Macrophage Differentiation and Contributes to CD8+ T-Cell DysfunctionFaria Ahmed, Andrea Ibrahim, Curtis L Cooper, et al.
Immunity, Inflammation and Disease|July 18, 2024
Reduced seasonal coronavirus incidence in high-risk population groups during the COVID-19 pandemicAliisa Heiskanen, Yannick Galipeau, Julian Little, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid ReviewAliisa Heiskanen, Yannick Galipeau, Marc-André Langlois, et al.
Annals of Hepatology|June 28, 2025
Chronic hepatitis B virus persistence: Mechanisms, consequences and implications for achieving cureChristopher Georgi, Simmone D'souza, Carla Osiowy, et al.
Clinical and Experimental Gastroenterology|March 20, 2012
Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysisEric Druyts, Edward J Mills, Jean Nachega, et al.
Pageof 13